Ezetimibe

insulin ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35307033 Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study). 2022 Mar 21 1
2 35571202 Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism. 2022 1
3 30519809 Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease. 2019 Jun 2
4 27714510 Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. 2016 Dec 1
5 25659874 The effect of ezetimibe on NAFLD. 2015 Feb 1
6 25704082 Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition. 2015 May 1
7 25969718 Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome. 2015 May 1
8 26336957 Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk. 2015 Sep 4 1
9 24354929 The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia. 2014 Apr 1
10 22353686 Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia. 2012 1
11 22878697 Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. 2012 1
12 22890076 Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load. 2012 Nov 1
13 21995692 Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance. 2011 Nov 3
14 20075600 The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. 2010 Feb 1
15 20385430 Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? 2010 Jun 1
16 16761194 Effect of ezetimibe on insulin sensitivity and lipid profile in obese and dyslipidaemic patients. 2006 Apr 3